Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00323362
What this trial is testing

Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Rutgers, The State University of New Jersey 17
Testing effectiveness (Phase 2)Looking for participantsNCT06910761
What this trial is testing

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more
City of Hope Medical Center 35
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Ended earlyNCT01935947
What this trial is testing

Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 17
Not applicableEnded earlyNCT02228421
What this trial is testing

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Metastatic
PeriPharm 29
Testing effectiveness (Phase 2)Study completedNCT02955758
What this trial is testing

Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma
Joel Neal 25
Large-scale testing (Phase 3)Looking for participantsNCT06745908
What this trial is testing

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

Who this might be right for
NSCLC Stage IV
ImmunityBio, Inc. 507
Not applicableActive Not RecruitingNCT05478538
What this trial is testing

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Metastatic NSCLC - Non-Small Cell Lung Cancer
Elephas 200
Not applicableStudy completedNCT03505515
What this trial is testing

Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer NSCLCSmall Cell Lung Cancer SCLC
Bristol-Myers Squibb 6,205
Not applicableUnknownNCT06000358
What this trial is testing

The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Stage IV
Lithuanian University of Health Sciences 120
Testing effectiveness (Phase 2)Looking for participantsNCT07362940
What this trial is testing

A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib

Who this might be right for
Non-Small Cell Lung Cancer
Henan Genuine Biotech Co., Ltd. 110
Testing effectiveness (Phase 2)Ended earlyNCT00040768
What this trial is testing

Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 35
Early research (Phase 1)Ended earlyNCT05621525
What this trial is testing

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced or Metastatic Non-small Cell Lung Cancer
LianBio LLC 7
Testing effectiveness (Phase 2)Study completedNCT00287989
What this trial is testing

Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Testing effectiveness (Phase 2)UnknownNCT04063462
What this trial is testing

Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Early research (Phase 1)WithdrawnNCT05171062
What this trial is testing

Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The University of Texas Health Science Center at San Antonio
Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Early research (Phase 1)Study completedNCT06525246
What this trial is testing

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+2 more
Ono Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)UnknownNCT02669719
What this trial is testing

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Chest Hospital 70
Next Page